Clinical Trial Update: Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating sequential therapy with tacrolimus and rituximab for membranous nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• Rituximab (rituximab)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Hospital Universitario 12 de Octubre | Conditions: MEMBRANOUS NEPHROPATHY | Phase 3 | Status: COMPLETED